CheckMyRecalls

Philips North America Llc recalls IntelliVue MP90 and 21 more

Published
10 Dec 2025
Units affected
22 products
Agency
FDA
Country
United States

The hazard

Potential issue where the IntelliVue monitors did not alarm.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

IntelliVue MP90. Product Number: M8010A.

IntelliVue MP30. Product Number: M8002A.

IntelliVue Patient Monitor MX800. Product Number: 865240.

IntelliVue Patient Monitor MX700. Product Number: 865241.

IntelliVue Patient Monitor MX500. Product Number: 866064.

IntelliVue Patient Monitor MX850. Product Number: 866470.

IntelliVue MP2. Product Number: M8102A.

IntelliVue MP50. Product Number: M8004A.

IntelliVue MP80. Product Number: M8008A.

IntelliVue Patient Monitor MX100. Product Number: 867033.

IntelliVue MP40. Product Number: M8003A.

IntelliVue Multi Measurement Server X2. Product Number: M3002A.

Brand / company
Philips North America Llc
Codes / lots
Product Number: M8010A; UDI-DI: 00884838000223; All Serial No. | Product Number: M8002A; UDI-DI: 00884838000155; All Serial No. | Product Number: 865240; UDI-DI: 00884838020733; All Serial No. | Product Number: 865241; UDI-DI: 00884838029088; All Serial No. | Product Number: 866064; UDI-DI: 00884838038776; All Serial No. | Product Number: 866470; UDI-DI: 00884838070790; All Serial No.
Distribution
Worldwide distribution - US Nationwide and the countries of Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belgium, Bolivia, Bosnia, Botswana, Brazil, Brunei, Bulgaria, Burundi, Cambodia, Canada, Cayman Islands, Chile, China, Colombia, Costa Rica, Cote D'Ivoire, Croatia, Cyprus, Czech Republic, Denmark, Dominican Rep, Ecuador, Egypt, El Salvador, Equat Guinea, Estonia, Ethiopia, Faroe Islands, Finland, French Polynesia, France, French Guiana, Gabon, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Guadeloupe, Guam, Guatemala, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Korea Rep, Kuwait, Lao, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Macao, Macedonia, Madagascar, Malaysia, Maldives, Mali, Malta, Martinique, Mauritius, Mayotte, Mexico, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, Netherlands Ant, New Caledonia, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Palestine, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, , R¿union, Romania, Russia, Saint Vincent, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, St. Pierre Mqln, Suriname, Sweden, Switzerland, Syrian Arab Rep, Taiwan, Tajikistan, Thailand, Trinidad Tobago, Tunisia, T¿rkiye, Turkmenistan, Uganda, Ukraine, United Kingdom, United States, Uruguay, Utd Arab Emir, Uzbekistan, Venezuela, Viet Nam, Virgin Isl (Br), Virgin Isl (US), White Russia, Yemen, Zambia, Zimbabwe.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 10 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.